Lifeline Biotechnologies Inc (LLBO)

[Penblanc]

Everything is very beautiful, years we read how it can be applied and with which system.
The problem is always that!
Still today we have no certainty, and as long as there is no FDA approach it is not going anywhere. And then there is the indispensable knot of the 5 billion shares in circulation, you need a reverse split, and finance teaches that at each reverse split the title slips a lot down.